Strong Q1 masks Spirits softness amid geopolitical headwinds

Revenue ₹2,988 Cr +19.4% YoY, PAT ₹96.8 Cr +32.2%, OPM 5.7%

Q1 delivered ₹120 Cr (annualizes to ₹480 Cr); growth 5.3%, IMFL +26%

IMFL grew 26% but volumes grew 55%; analyst noted revenue did not grow proportionately

Growth 40% but below target; export headwinds (Middle East collapsed), propylene oxide constraints

Finance cost decline corroborates debt reduction trajectory

New-to-call guidance: Potable Spirits >₹500 Cr EBITDA FY27. No prior numeric Spirits guide to compare; represents formalization of strategy into near-term target.

Best-ever quarter ₹83 Cr revenue (+65% YoY), EBITDA >100% growth. Prior FY26 calls did not emphasize this segment as a growth pillar; now central to portfolio.

FY26 call promised growth in value-added chemicals. Q1 showed 40% growth but below target, with exports to Middle East 'completely collapsed' due to geopolitics; a structural setback vs. prior optimism.

Finance costs ₹45 Cr (Q1 FY26) → ₹25 Cr (Q1 FY27); debt-to-equity improved. Debt-free FY28 target reaffirmed; aligns with prior guidance.

EBITDA >₹500 Cr FY27 (₹120 Cr in Q1). Doubling volumes YoY. Industry CAGR 4-5%; we expect healthy double-digit growth FY28.

INR5-20 Cr capex (not intensive). Aspire to ₹150 Cr+ this year, ₹600-700 Cr in 4-5 yrs with 16-17% → 30% gross margins by 2030.

Fair assumption PAT trend continues. Headwinds from ethylene oxide pricing eased; JV done well despite 4-year challenges. Actions on product mix and pricing helping.

0.5 million cases, almost double YoY. Total IMFL 1.4 million. FY26 IMFL was 3.4 million cases full year.

State mix (Delhi lower-value vs Uttarakhand premium) and brand mix (mass premium grew faster). FY27 outlook: Deluxe, Semi-Prem Vodka, White Spirits launches will improve revenue vs volume.

Best-ever quarter ₹83 Cr, growth 65%. Raw material 'volatility and challenge in Q2 as well.' Nicotine expanded; branded portfolio focus continuing.

Potable Spirits different from B2B chemicals; need investor clarity. Consumer biz attracts different partners/investors than B2B tech business. Better focus and differentiation.

Q1 ₹120 Cr implies ₹480 Cr annualized; requires acceleration H2. Doubled volumes targeted. New brands (Deluxe Whiskey, Semi-Premium Vodka) planned.

Labeled 'aspiration' not guidance. Current annualized ~₹40 Cr EBITDA; 3.75x growth requires strong acceleration. Geopolitical headwinds on exports.

Vague; no numeric target. Industry CAGR 4-5%; management expects to beat it with premiumization, but Q1 +5.3% organic is soft.

Q1 achieved 22.9%. New SKU launches (Deluxe, Semi-Prem) flagged as high-margin; if realized, margin expansion possible.

Aspiration-level; implies mix shift to performance chemicals. Currently performance chemicals only 40% growth; headwinds in place.

Modular expansion model. Not capex-intensive this year. Future large capex only for new tech investments (post FY28).

FY27 Spirits EBITDA >₹500 Cr guidance; Q1 ₹120 Cr annualizes to ₹480 Cr. Requires H2 acceleration or margin expansion. Organic growth only 5.3% contradicts aggressive target.

Middle East oil-and-gas specialty chemicals exports 'completely collapsed' due to Ukraine war. Performance chemicals growth 40% but missed target due to export headwinds and propylene oxide supply constraints.

Ennature posted best-ever quarter (+65% revenue, ~100% EBITDA growth) but raw material 'volatility and challenge in Q2 as well' flagged. Thiocolchicoside and nicotine crude input costs unpredictable.

NCLT approval received but effective date not yet announced. Three-entity separation (Spirits, Chemicals, Ennature) requires cost allocation, shared services, regulatory compliance. Operational disruption possible during transition.

IMFL volumes +55% but revenue +26%, implying average price decline. State mix (Delhi lower-value, Uttarakhand premium) and brand mix (mass premium vs. prestige) drag pricing. Premiumization narrative may not materialize.